Join the first ISARIC Data Tools Webinar! 📅 Fri 24 Oct 2025 🕛 12:00 PM BST Learn about the ISARIC Clinical Epidemiology Platform & tools - ARC, BRIDGE & VERTEX. 🔗 Learn more 👉 https://t.co/ZrWestqHZj #ISARIC #ClinicalResearch #GlobalHealth

Last week, the ISARIC Leadership Programme for Scientists was launched in collaboration with @unisabana and @INALDE. 👩‍💻 Read what Programme Manager Dr Luis Felipe Reyes says about the programme being hosted in Columbia below 👇 Read more 👉 https://t.co/brWiMLpW8E

📢 A major collaboration between #ISARIC researchers at @KingsCollegeLon and the @OUCRU_Programme has created the first global Core Outcome Measurement Set for #dengue clinical trials.🏥 Read more 👉 https://t.co/lDzXdXy5F0

An important part of building acute care research capacity in the Global South is bringing the scientific discussion there. @ISARIC1 @CCCTG_ @CCCTG_Ire @anzics @CritCareReviews @CIIC_HIN @AcuteCareTrials @CIHR_ICRH @CCIRNet @bricnetbr

📢 In partnership with @ucts_unisabana, we have launched the ISARIC Programme for Scientists, empowering mid-career women researchers in LMICs to become future PIs 🌍 Read more 👉 https://t.co/5qUWIA97nn

In a global first, @PSIOxford and @ISARIC1 researchers, plus partners in 🇬🇧 and 🇲🇬, have successfully conducted a clinical trial for #BubonicPlague treatment - providing the first safety and efficacy evidence of antibiotic regimens 💊 Read more 👉 https://t.co/pOX83XQTmL

Data on treatments for bubonic plague are limited. In this open-label, randomized, controlled trial in Madagascar, ciprofloxacin monotherapy was noninferior to a standard aminoglycoside–ciprofloxacin regimen. Full IMASOY trial results: https://t.co/N42b8KPRxE Editorial:

NEW: Oxford researchers, working with partners in the UK and Madagascar through @ISARIC1, have carried out the world’s first rigorous clinical trial for bubonic plague treatments. ⬇️

For the first time, these antibiotics have been found to be safe and effective, and that a treatment of just oral antibiotics is a safe and effective alternative to existing treatment requiring injectable antibiotics and hospitalisation. 🏥 Read more👉 https://t.co/BmccGdDFS7

💊 Bubonic plague is prevalent in the Malagasy highlands. It is currently treated with antibiotics that, until now, had not been rigorously tested in humans.

🦠 Plague is caused by the bacterium Yersinia pestis and has had devastating effects on humanity for nearly 5000 years. #Bubonicplague is the most common form, and manifests in painful lumps called ‘buboes’.

📢 #ISARIC researchers have carried out the world’s first rigorous clinical trial of treatments for #bubonicplague. 🧵 @NEJM @pasteurMG @MsppOfficiel @LSHTM @PSIOxford @UniofOxford @NDMOxford @FCDOGovUK @wellcometrust

📄 A new study investigating stigma during the 2022 #Ebola outbreak in central Uganda highlights its impact on outbreak control, as well as strategies for reducing stigma in future outbreaks. Read the paper 👉 https://t.co/EXKa7N4k29

The new @WHO #PandemicAgreement outlines new architecture for global solidarity in times of crisis, using several core provisions that could significantly improve future #pandemic preparedness and response. Read more👉  https://t.co/dgNwKu6yTP @drzakiul @UniofOxford @PSIOxford

📢 Stigma is a critical factor influencing how disease #outbreaks are controlled. Now, #ISARIC researchers have created the first standardised tool to help health professionals measure #stigma. Read more 👉 https://t.co/mnn6PtKCbi @WalimuNGO @NDMOxford @TheLancetInfDis

🌟 We are honoured to be named finalists in the prestigious Vice-Chancellor’s Awards 2025 – the University of Oxford’s highest recognition of excellence across teaching, research, and service. GOARNs Orientation to International Outbreak Response workshop, “Preparing the next

A new study by #ISARIC researchers has produced an explanatory analytical model of stigma during disease outbreaks. Read more 👉 https://t.co/uwhFredosc

🌍 In response to the growing global threat of #H5N1, #ISARIC has adapted its outbreak research response tools to support a standardised and coordinated approach for healthcare and research centres. Read more on our website 👉 https://t.co/hqpaEfw27z

Dr Lubaba Shahrin, successful candidate of our recent call for partners to help expand the delivery and implementation of the #ISARIC CCP, explains what made her respond to the call. 👇 Read more on our website 👉 https://t.co/AOHbEJMxIK

🎉We’re delighted that the MSc workshop we delivered in partnership with @TropMedOxford, @WHOGOARN, @WOAH, and leading academic institutions has been shortlisted for this year’s @UniofOxford Vice Chancellor’s Awards! Read more 👉 https://t.co/SCUBJ1CQBn